Search Results - "Frisell, T"

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies by Luna, Gustavo, Alping, Peter, Burman, Joachim, Fink, Katharina, Fogdell-Hahn, Anna, Gunnarsson, Martin, Hillert, Jan, Langer-Gould, Annette, Lycke, Jan, Nilsson, Petra, Salzer, Jonatan, Svenningsson, Anders, Vrethem, Magnus, Olsson, Tomas, Piehl, Fredrik, Frisell, Thomas

“…Although highly effective disease-modifying therapies for multiple sclerosis (MS) have been associated with an increased risk of infections vs injectable…”
Get more information

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients by Alping, Peter, Frisell, Thomas, Novakova, Lenka, Islam-Jakobsson, Protik, Salzer, Jonatan, Björck, Anna, Axelsson, Markus, Malmeström, Clas, Fink, Katharina, Lycke, Jan, Svenningsson, Anders, Piehl, Fredrik

“…Objective Many JC virus antibody‐positive relapsing–remitting multiple sclerosis (RRMS) patients who are stable on natalizumab switch to other therapies to…”
Get full text

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients by Alping, Peter, Askling, Johan, Burman, Joachim, Fink, Katharina, Fogdell‐Hahn, Anna, Gunnarsson, Martin, Hillert, Jan, Langer‐Gould, Annette, Lycke, Jan, Nilsson, Petra, Salzer, Jonatan, Svenningsson, Anders, Vrethem, Magnus, Olsson, Tomas, Piehl, Fredrik, Frisell, Thomas

“…Objective Novel, highly effective disease‐modifying therapies have revolutionized multiple sclerosis (MS) care. However, evidence from large comparative…”
Get full text

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial by Piehl, Fredrik, Eriksson-Dufva, Ann, Budzianowska, Anna, Feresiadou, Amalia, Hansson, William, Hietala, Max Albert, Håkansson, Irene, Johansson, Rune, Jons, Daniel, Kmezic, Ivan, Lindberg, Christopher, Lindh, Jonas, Lundin, Fredrik, Nygren, Ingela, Punga, Anna Rostedt, Press, Rayomand, Samuelsson, Kristin, Sundström, Peter, Wickberg, Oskar, Brauner, Susanna, Frisell, Thomas

“…Rituximab is a third-line option for refractory generalized myasthenia gravis (MG) based on empirical evidence, but its effect in new-onset disease is unknown…”
Get more information

Violent crime runs in families: a total population study of 12.5 million individuals by Frisell, T, Lichtenstein, P, Långström, N

“…Etiological theory and prior research with small or selected samples suggest that interpersonal violence clusters in families. However, the strength and…”
Get more information

Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data by Barbulescu, Andrei, Askling, Johan, Chatzidionysiou, Katerina, Forsblad-d’Elia, Helena, Kastbom, Alf, Lindström, Ulf, Turesson, Carl, Frisell, Thomas

“…Abstract Objectives To describe the use of baricitinib and tofacitinib by Swedish RA patients and to compare their effectiveness with that of biologic DMARDs…”
Get full text

Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial by Svenningsson, Anders, Frisell, Thomas, Burman, Joachim, Salzer, Jonatan, Fink, Katharina, Hallberg, Susanna, Hambraeus, Joakim, Axelsson, Markus, Nimer, Faiez Al, Sundström, Peter, Gunnarsson, Martin, Johansson, Rune, Mellergård, Johan, Rosenstein, Igal, Ayad, Ahmad, Sjöblom, Irina, Risedal, Anette, de Flon, Pierre, Gilland, Eric, Lindeberg, Jonas, Shawket, Fadi, Piehl, Fredrik, Lycke, Jan

“…B-cell depleting therapies are highly efficacious in relapsing-remitting multiple sclerosis but one such therapy, rituximab, is not approved for multiple…”
Get full text

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme by Frisell, Thomas, Bower, Hannah, Morin, Matilda, Baecklund, Eva, Di Giuseppe, Daniela, Delcoigne, Benedicte, Feltelius, Nils, Forsblad-d'Elia, Helena, Lindqvist, Elisabet, Lindström, Ulf, Askling, Johan

“…Longitudinal clinical registry-infrastructures such as Anti-Rheumatic Therapies in Sweden (ARTIS) allow simultaneous comparison of the safety of individual…”
Get more information

The Association Between Schizophrenia and Rheumatoid Arthritis: A Nationwide Population-Based Swedish Study on Intraindividual and Familial Risks by SELLGREN, Carl, FRISELL, Thomas, LICHTENSTEIN, Paul, LANDEN, Mikael, ASKLING, Johan

“…Numerous studies have reported a reduced risk of rheumatoid arthritis (RA) in schizophrenia. The mechanisms are unknown, but recent genome-wide association…”
Get full text

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics by Frisell, Thomas, Baecklund, Eva, Bengtsson, Karin, Di Giuseppe, Daniela, Forsblad-d'Elia, Helena, Askling, Johan

“…With the wide range of biological disease-modifying anti-rheumatic drugs (bDMARDs) available for treating rheumatoid arthritis (RA), and limited evidence to…”
Get more information

Familial clustering of suicide risk: a total population study of 11.4 million individuals by Tidemalm, D, Runeson, B, Waern, M, Frisell, T, Carlström, E, Lichtenstein, P, Långström, N

“…Research suggests that suicidal behaviour is aggregated in families. However, due to methodological limitations, including small sample sizes, the strength and…”
Get more information

Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden by Di Giuseppe, Daniela, Lindstrom, Ulf, Bower, Hannah, Delcoigne, Bénédicte, Frisell, Thomas, Chatzidionysiou, Katerina, Sjöwall, Christopher, Lindqvist, Elisabet, Askling, Johan

“…To compare treatment retention between biosimilars and their originator products among first starters (etanercept, infliximab, adalimumab and rituximab), as…”
Get full text

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis by Boremalm, M., Juto, A., Axelsson, M., Novakova, L., Frisell, T., Svenningsson, A., Lycke, J., Piehl, F., Salzer, J.

“…Background and purpose Breakthrough disease on first‐line injectables in relapsing‐remitting multiple sclerosis (RRMS) is a common clinical situation where…”
Get full text

Psychiatric morbidity associated with same-sex sexual behaviour: influence of minority stress and familial factors by Frisell, T, Lichtenstein, P, Rahman, Q, Långström, N

“…Increased psychiatric morbidity has been widely reported among non-heterosexual individuals (defined as reporting a homosexual/bisexual identity and/or…”
Get more information

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy by Longinetti, Elisa, Englund, Simon, Burman, Joachim, Fink, Katharina, Fogdell-Hahn, Anna, Gunnarsson, Martin, Hillert, Jan, Langer-Gould, Annette Magdalene, Lycke, Jan, Nilsson, Petra, Salzer, Jonatan, Svenningsson, Anders, Mellergård, Johan, Olsson, Tomas, Piehl, Fredrik, Frisell, Thomas

“…BackgroundWe analysed the COMparison Between All immunoTherapies for Multiple Sclerosis (NCT03193866), a Swedish nationwide observational study in…”
Get full text

Is family history a predictor of response to tumour necrosis factor inhibitors in spondyloarthritis? A Swedish nationwide cohort study by Morin, M, Hellgren, K, Lindström, U, Frisell, T

“…Objective: To determine whether a family history of spondyloarthritis (SpA) is associated with clinical presentation at the start of tumour necrosis factor…”
Get full text

Risk Factors for the Rapid Increase in Risk of Acute Coronary Events in Patients With New‐Onset Rheumatoid Arthritis: A Nested Case–Control Study by Mantel, Ängla, Holmqvist, Marie, Nyberg, Fredrik, Tornling, Göran, Frisell, Thomas, Alfredsson, Lars, Askling, Johan

“…Objective To investigate risk factors for acute coronary syndrome (ACS) in patients with new‐onset rheumatoid arthritis (RA). Methods We performed a nested…”
Get full text

Hospital Admission With Infection During Childhood and Risk for Psychotic Illness—A Population-based Cohort Study by BLOMSTRÖM, Asa, KARLSSON, Håkan, SVENSSON, Anna, FRISELL, Thomas, LEE, Brian K, DAL, Henrik, MAGNUSSON, Cecilia, DALMAN, Christina

“…A growing body of literature suggests that exposure to infections, particularly maternal infections, during pregnancy confers risk for later development of…”
Get full text

Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer by Jansson, Fredrik, Drevin, Linda, Frisell, Thomas, Stattin, Pär, Bratt, Ola, Akre, Olof

“…Purpose Prostate cancer among first-degree relatives is a strong risk factor for diagnosis of prostate cancer, and the contribution of heritable factors in…”
Get full text

Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis by Sysojev, Anton Öberg, Saevarsdottir, Saedis, Diaz-Gallo, Lina-Marcela, Silberberg, Gilad N, Alfredsson, Lars, Klareskog, Lars, Baecklund, Eva, Björkman, Lena, Kastbom, Alf, Rantapää-Dahlqvist, Solbritt, Turesson, Carl, Jonsdottir, Ingileif, Stefansson, Kari, Frisell, Thomas, Padyukov, Leonid, Askling, Johan, Westerlind, Helga

“…To investigate the influence of genetic factors on persistence with treatment of early RA with MTX monotherapy. We conducted a genome-wide association study…”
Get full text